Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
Pharmasyntez-Medtech
BratskChemSyntez
Export
Аll
2025
2024
2023
2022
2018
04.12.2025
Pharmasyntez Starts Growing the Russian-Mongolian Alliance
Read more
03.12.2025
Pharmasyntez Discusses Potential Collaboration with the New Chinese Consul General in Irkutsk
Read more
06.11.2025
Pharmasyntez Representatives Deliver Open Lecture for SibSU Students
Read more
19.03.2024
Pharmasyntez is a participant of the round table Modern Technological Support of Pharmaceutical Production
Read more
28.02.2024
The Pharmasyntez Group of Companies released the first batch of the drug Ferligand into civil circulation
Read more
16.02.2024
The Minister of Economic Development of the Irkutsk Region visited Pharmasyntez JSC together with students
Read more
17.01.2024
Chinese diplomats visited the Irkutsk plant of the Pharmasyntez Group of Companies
Read more
15.01.2024
The Pharmasyntez Group of Companies is a partner in a large-scale project in the Siberian Region Ice City. Pure Water Happiness
Read more
08.11.2023
The Pharmasyntez Group of Companies took part in the annual Regional Youth Career Forum (2023)
Read more
03.11.2023
A business meeting between JSC Pharmasyntez and chancellor office of the Institute of Chemical Technologies of the Siberian State University of Science and Technology named after M.F. Reshetnev
Read more
23.08.2023
Nomides® suspension in new volumes
Read more
15.06.2023
Pharmasyntez and Irkutsk Region defined social activities for 2023
Read more
23.05.2023
Pharmasyntez employees took part in the Green Marathon
Read more
28.04.2023
The Irkutsk administration and Pharmasyntez have signed an agreement on social and economic cooperation
Read more
02.02.2023
Winners of “Leaders of Russia” competition visited Pharmasyntez JSC
Read more
13.09.2022
Minister of Healthcare of the Republic of the Union of Myanmar expressed great interest in purchasing the Pharmasyntez Group of Companies’ products
Read more
News:
← предыдущая
1
2
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
Pharmasyntez-Medtech
BratskChemSyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez
Pharmasyntez-Medtech